Assignment of Benefits was a bad idea. Let’s hope it never comes back.
Assignment of Benefits (AOB) is an idea that rears its head periodically in the North Carolina General Assembly. This year it was put forward in House Bill 562 and could have cost North Carolinians as much as $2.2 billion in higher health care costs.
The myth of “patient wishes” and HB 562
HB 562, which could cost North Carolina as much as $2.2 billion, was rightfully not given a favorable report from the House Insurance Committee after a heated but respectful discussion from the members of the committee.
Check your EOB – HB721 would make you pay THAT for an email from your doctor
f you have health insurance, you’re probably familiar with EOBs – explanation of benefits – statements. They give you all the critical information regarding the costs of any care you get. They include what the doctor’s price is, what the negotiated rate (“Allowed Amount”) is with your insurer, how much you may owe, etc…
Safely Save Money on Prescription Drugs with These Six Tips
In a Kaiser Family Foundation (KFF) health tracking poll completed in February, nearly eight in ten Americans said the cost of prescription drugs is “unreasonable.” As a means of combating those rising costs, consumers have implemented a number of unhealthy strategies meant to make prescriptions last longer and lighten the financial burden, including rationing or skipping doses completely.
NC's House Bill 721 (on Telehealth) Will Be Bad for Your Fiscal Health
Telehealth (you may have heard of it as telemedicine, too) is the medical wave of the future. It means connecting with your doctor’s office over the internet. If you’re stuck at home for some reason but really need medical care, you may get healthier faster if you can talk to the doc right from your couch. And telemedicine can save the overall system money, too — or so goes the common wisdom. Seems like a great idea, right? Sure.
Big Pharma’s Attempt At Providing Clear Pricing Information Not So Clear After All
Last fall, as the Trump administration was breathing down the necks of Big Pharma about being more forthcoming with information on drug prices for consumers, it appeared that manufacturers heard the request loud and clear. While the government wanted these companies to begin including list prices in TV advertisements, the Pharmaceutical Research and Manufacturers of America (PhRMA) seemed to beat them to the punch—proposing voluntary action it said would help clear up any ambiguities around pricing.